Stocklytics Platform
Asset logo for symbol LIVN
LivaNova PLC
LIVN64
$41.86arrow_drop_down2.66%-$1.14
Asset logo for symbol LIVN
LIVN64

$41.86

arrow_drop_down2.66%
no data available for key stats

There's no data available for key stats

no data available for ratios/profitability stats

There's no data available for ratios/profitability stats

Fundamentals
Payout Ratio-
Industry average yield2.89%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

LIVN-
US Healthcare Sector-
US Market-
warning

LIVN / Market

LIVN lose to the US Market which returned 0.03% over the last twenty four hours.
warning

LIVN / Healthcare Sector

LIVN lose to the US Healthcare sector which returned 2.60% over the last twenty four hours.

LivaNova PLC (LIVN) Statistics

LivaNova PLC, ticker symbol LIVN, is a global medical technology company that specializes in the development and manufacturing of innovative treatment solutions for cardiovascular and neuromodulation conditions. The company aims to improve the lives of patients around the world by delivering cutting-edge therapies and technologies. LivaNova PLC is listed on the Nasdaq stock exchange and is headquartered in London, United Kingdom.
When it comes to evaluating the valuation metrics of LivaNova PLC, several factors come into play. These include the company's market capitalization, earnings per share, and price-to-earnings ratio, among others. Investors often analyze these metrics to determine the relative value of LIVN stock compared to its peers and the overall market. Additionally, LivaNova PLC's fundamentals, such as revenue growth, profit margins, and total debt, provide insights into the company's financial health and stability.
add LivaNova PLC to watchlist

Keep an eye on LivaNova PLC

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has LivaNova PLC (LIVN) stock's performance compared to its sector and the market over the past year?

Over the past year, LivaNova PLC (LIVN) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 15.12%, LivaNova PLC has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 23.87%, it has fallen short of the market average. This comparison highlights LivaNova PLC's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of LivaNova PLC (LIVN) stock?

The PE (Price to Earnings) ratio of LivaNova PLC (LIVN) is currently 36.09. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of LivaNova PLC (LIVN) stock?

The Earnings Per Share (EPS) for LivaNova PLC (LIVN), calculated on a diluted basis, is $1.16. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of LivaNova PLC (LIVN) stock?

The operating margin for LivaNova PLC (LIVN) is 11.05%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of LivaNova PLC (LIVN) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of LivaNova PLC (LIVN) is $211.39M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does LivaNova PLC (LIVN) have?

LivaNova PLC (LIVN) has a total debt of $676.77M. The net debt, which accounts for cash and cash equivalents against the total debt, is $238.8M.

Take Your Investments to a Whole New Level